Global Alpha Dumps 229,000 Shares: Market Move Explained
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
This overview explains risk parity investing and how allocating risk rather than capital can influence retirement portfolio stability.
26,917 articlesA major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
A rare two-step upgrade on Intel hints at a shifting AI investment narrative. This article breaks down what it means ...
Peloton has faced a brutal selloff, but the story isn’t finished. This article dives into whether Peloton is broken o...
SpaceX presents a compelling growth story, but timing a public debut or future entry requires discipline. This guide ...
Cardano has struggled to deliver on big promises, leaving many investors looking for cryptocurrencies that better buy...
SpaceX stock shines in the headlines, but the math behind the hype isn’t adding up for me. Here are four practical re...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
XRP has pulled back from its highs, trading around $1.44 after a loss from a $3.65 peak. Three major catalysts could ...
Hype around SpaceX can obscure solid growth opportunities. Here are two AI-driven stock picks that offer clearer earn...